Novopen Echo® for the Delivery of Insulin: A Comparison of Usability, Functionality and Preference among Pediatric Subjects, Their Parents, and Health Care Professionals
Authors:
- Birthe S. OlsenBOBirthe S. Olsen
- Conny Nøhr KorsholmCKConny Nøhr Korsholm
Open Access
- 1 November 2010
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 4 (6) , 1468-1475
Abstract
Despite advances in insulin pen design and functionality, the selection of pens available for children with diabetes is limited. This study assessed the usability, functionality and attitudes towards NovoPen Echo®, a new durable insulin pen designed for pediatric patients that combines a simple memory function with half-increment dosing, versus NovoPen® Junior and HumaPen® Luxura® HD in pediatric subjects, their parents, and health care professionals (HCPs). Pens were evaluated in random order during 1:1 interviews in the three target groups (pediatric subjects, parents, and HCPs) in Germany, France, and Canada. Study participants were asked to prepare each pen, perform injections into foam cushions, and provide feedback via a standardized questionnaire. In total, 205 participants were included in the study. On a scale of 1–6 (1 = most favorable; 6 = least favorable regarding overall appearance, shape, colors, thickness and length), NovoPen Echo received the most favorable rating for design and overall appearance (mean ± standard deviation = 1.71 ± 0.79) compared with NovoPen Junior (2.02 ± 0.93) and HumaPen Luxura HD (2.36 ± 1.01). Furthermore, 89% of pediatric subjects and 94% of parents rated the memory function of NovoPen Echo as very easy/easy to use. When asked to rate the pens overall, 80% of participants preferred NovoPen Echo to the other pens (p < 0.0001). The results demonstrate a high overall level of satisfaction with NovoPen Echo among pediatric subjects, parents, and HCPs. The novel design aspects of NovoPen Echo, namely t1468-he simple memory function, half-increment units and, ease of use and design, may contribute towards promoting treatment adherence, which is essential in the pediatric setting.Keywords
This publication has 14 references indexed in Scilit:
- Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetesPediatric Diabetes, 2009
- Insulin delivery with FlexPen®: dose accuracy, patient preference and adherenceExpert Opinion on Drug Delivery, 2008
- An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringeCurrent Medical Research and Opinion, 2006
- Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims dataClinical Therapeutics, 2006
- A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countriesPediatric Diabetes, 2005
- Compliance and administration methods in management of type 1 diabetes.2005
- A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitusClinical Therapeutics, 2003
- Phobia of self‐injecting and self‐testing in insulin‐treated diabetes patients: opportunities for screeningDiabetic Medicine, 2001
- Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringesArchives of Disease in Childhood, 1998
- Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitusThe Lancet, 1997